全身发作性癫痫

参考文献

关键文献

Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-30.全文  摘要

Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21.全文  摘要

Bernasconi A, Cendes F, Theodore WH, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019 Jun;60(6):1054-68. 摘要

Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults. Neurology. 2015 Apr 21;84(16):1705-13.全文  摘要

Campos MSA, Ayres LR, Morelo MRS, et al. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int J Clin Pharm. 2018 Jun;40(3):589-98. 摘要

Boon P, De Cock E, Mertens A, et al. Neurostimulation for drug-resistant epilepsy: a systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response. Curr Opin Neurol. 2018 Apr;31(2):198-210. 摘要

参考文献

1. International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981 Aug;22(4):489-501. 摘要

2. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-30.全文  摘要

3. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21.全文  摘要

4. Hauser W, Kurland L. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia. 1975 Mar;16(1):1-66. 摘要

5. Juul-Jensen P, Foldspang A. Natural history of epileptic seizures. Epilepsia. 1983 Jun;24(3):297-312. 摘要

6. Tsuboi T. Prevalence and incidence of epilepsy in Tokyo. Epilepsia. 1988 Mar-Apr;29(2):103-10. 摘要

7. Myers CT, Mefford HC. Advancing epilepsy genetics in the genomic era. Genome Med. 2015 Aug 25;7:91.全文  摘要

8. Ellis CA, Petrovski S, Berkovic SF. Epilepsy genetics: clinical impacts and biological insights. Lancet Neurol. 2020 Jan;19(1):93-100. 摘要

9. Anderson E, Berkovic S, Dulac O, et al. ILAE genetics commission conference report: molecular analysis of complex genetic epilepsies. Epilepsia. 2002 Oct;43(10):1262-7.全文  摘要

10. Santos BPD, Marinho CRM, Marques TEBS, et al. Genetic susceptibility in juvenile myoclonic epilepsy: systematic review of genetic association studies. PLoS One. 2017 Jun 21;12(6):e0179629.全文  摘要

11. El Achkar CM, Olson HE, Poduri A, et al. The genetics of the epilepsies. Curr Neurol Neurosci Rep. 2015 Jul;15(7):39. 摘要

12. Prince DA, Connors BW. Mechanisms of interictal epileptogenesis. Adv Neurol. 1986;44:275-99. 摘要

13. Rao VR, Lowenstein DH. Epilepsy. Curr Biol. 2015 Aug 31;25(17):R742-6.全文  摘要

14. Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia. 2005;46 Suppl 9:10-4.全文  摘要

15. Pedersen E. Postencephalitic epilepsy. Epilepsia. 1964 Mar;5:43-50. 摘要

16. Chen YJ, Fang PC, Chow JC, et al. Clinical characteristics and prognostic factors of postencephalitic epilepsy in children. J Child Neurol. 2006 Dec;21(12):1047-51. 摘要

17. Rao VR, Parko KL. Clinical approach to posttraumatic epilepsy. Semin Neurol. 2015 Feb;35(1):57-63.全文  摘要

18. Wyllie E, ed. The treatment of epilepsy: principles and practice. Lippincott Williams & Wilkins; 2006.

19. Scher MS, Aso K, Beggarly ME, et al. Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics. 1993 Jan;91(1):128-34. 摘要

20. Holanda MR, Melo AN. Comparative clinical study of preterm and full-term newborn neonatal seizures. Arq Neuropsiquiatr. 2006 Mar;64(1):45-50.全文  摘要

21. Ronen G, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr. 1999 Jan;134(1):71-5. 摘要

22. Nelson KB, Ellenberg JH. Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med. 1976 Nov 4;295(19):1029-33. 摘要

23. Van der Berg BJ, Yerushalmy J. Studies on convulsive disorders in young children. I. Incidence of febrile and nonfebrile convulsions by age and other factors. Pediatr Res. 1969 Jul;3(4):298-304. 摘要

24. Wallace SJ. Recurrence of febrile convulsions. Arch Dis Child. 1974 Oct;49(10):763-5.全文  摘要

25. National Institute for Health and Care Excellence. Transient loss of consciousness ('blackouts') in over 16s. Sep 2014 [internet publication].全文

26. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4. 摘要

27. Arendt K, Demaerschalk BM, Wingerchuk DM, Camann W. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20. 摘要

28. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204. 摘要

29. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.全文  摘要

30. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.全文  摘要

31. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.全文  摘要

32. Chen DK, So YT, Fisher RS, et al. Use of serum prolactin in diagnosing epileptic seizures. Neurology. 2005 Sep 13;65(5):668-75.全文  摘要

33. Sundararajan T, Tesar GE, Jimenez XF. Biomarkers in the diagnosis and study of psychogenic nonepileptic seizures: a systematic review. Seizure. 2016 Feb;35:11-22.全文  摘要

34. Wyllie E, Lueders H, Pippenger C, et al. Postictal serum creatine kinase in the diagnosis of seizure disorders. Arch Neurol. 1985 Feb;42(2):123-6. 摘要

35. Libman MD, Potvin L, Coupal L, et al. Seizure vs. syncope: measuring serum creatine kinase in the emergency department. J Gen Intern Med. 1991 Sep-Oct;6(5):408-12. 摘要

36. Neufeld MY, Treves TA, Chistik V, et al. Sequential serum creatine kinase determination differentiates vaso-vagal syncope from generalized tonic-clonic seizures. Acta Neurol Scand. 1997 Mar;95(3):137-9. 摘要

37. Tatum WO, Rubboli G, Kaplan PW, et al. Clinical utility of EEG in diagnosing and monitoring epilepsy in adults. Clin Neurophysiol. 2018 May;129(5):1056-82.全文  摘要

38. American Clinical Neurophysiology Society. Guideline twelve: guidelines for long-term monitoring for epilepsy. J Clin Neurophysiol. 2008 Jun;25(3):170-80.全文  摘要

39. Bernasconi A, Cendes F, Theodore WH, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019 Jun;60(6):1054-68. 摘要

40. Van Donselaar CA, Schimsheimer RJ, Geerts AT, et al. Value of the electroencephalogram in adult patients with untreated idiopathic first seizures. Arch Neurol. 1992 Mar;49(3):231-7. 摘要

41. Schreiner A, Pohlmann-Eden B. Value of the early electroencephalogram after a first unprovoked seizure. Clin Electroencephalogr. 2003 Jul;34(3):140-4. 摘要

42. Gilbert DL, Sethuraman G, Kotagal U, et al. Meta-analysis of EEG test performance shows wide variation among studies. Neurology. 2003 Feb 25;60(4):564-70. 摘要

43. Burkholder DB, Britton JW, Rajasekaran V, et al. Routine vs extended outpatient EEG for the detection of interictal epileptiform discharges. Neurology. 2016 Apr 19;86(16):1524-30.全文  摘要

44. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989 Jul-Aug;30(4):389-99. 摘要

45. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on Classification and Terminology. Epilepsia. 2001 Jun;42(6):796-803.全文  摘要

46. Berg AT, Berkovic SF, Brodie MG, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010 Apr;51(4):676-85.全文  摘要

47. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014 Apr;55(4):475-82.全文  摘要

48. Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults. Neurology. 2015 Apr 21;84(16):1705-13.全文  摘要

49. Leone MA, Giussani G, Nolan SJ, et al. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database Syst Rev. 2016 May 6;(5):CD007144.全文  摘要

50. Shorvon SD, Bermejo PE, Gibbs AA, et al. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection. Epilepsy Behav. 2018 May;82:91-103.全文  摘要

51. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000 Feb 3;342(5):314-9.全文  摘要

52. Mohanraj R, Brodie MJ. Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting. Acta Neurol Scand. 2007 Mar;115(3):204-8. 摘要

53. Shih JJ, Ochoa JG. A systematic review of antiepileptic drug initiation and withdrawal. Neurologist. 2009 May;15(3):122-31. 摘要

54. Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology. 2002 Apr 23;58(8 Suppl 5):S2-8. 摘要

55. Palleria C, Cozza G, Khengar R, et al. Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review. Curr Pharm Des. 2017;23(37):5606-5624.全文  摘要

56. Perucca E, Brodie MJ, Kwan P, et al. 30 years of second-generation antiseizure medications: impact and future perspectives. Lancet Neurol. 2020 Jun;19(6):544-56. 摘要

57. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. Mar 2018 [internet publication].全文

58. Medicines and Healthcare products Regulatory Agency. Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review. Jan 2021 [internet publication].全文

59. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA. 2004 Feb 4;291(5):605-14.全文  摘要

60. Smith CT, Marson AG, Chadwick DW, et al. Multiple treatment comparisons in epilepsy monotherapy trials. Trials. 2007 Nov 5;8:34.全文  摘要

61. Campos MSA, Ayres LR, Morelo MRS, et al. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int J Clin Pharm. 2018 Jun;40(3):589-98. 摘要

62. Glauser T, Ben-Menachem E, Bourgeois B, et al; ILAE Subcommission on AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013 Mar;54(3):551-63.全文  摘要

63. Nevitt SJ, Marson AG, Weston J, et al. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2018 Aug 9;(8):CD001769.全文  摘要

64. Nevitt SJ, Sudell M, Weston J, et al. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2017 Dec 15;(12):CD011412.全文  摘要

65. Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy. Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Curr. 2018 Jul-Aug;18(4):260-8.全文  摘要

66. Nevitt SJ, Sudell M, Tudur Smith C, et al. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2019 Jun 24;(6):CD012065.全文  摘要

67. Nevitt SJ, Tudur Smith C, Weston J, et al. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2018 Jun 28;(6):CD001031.全文  摘要

68. Nevitt SJ, Tudur Smith C, Marson AG. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2018 Oct 23;(10):CD003615.全文  摘要

69. Brodie MJ, Perucca E, Ryvlin P, et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007 Feb 6;68(6):402-8. 摘要

70. Marson AG, Williamson PR, Clough H, et al. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia. 2002 May;43(5):505-13. 摘要

71. McAuley JW, Biederman TS, Smith JC, et al. Newer therapies in the drug treatment of epilepsy. Ann Pharmacother. 2002 Jan;36(1):119-29. 摘要

72. Hoy SM. Lacosamide: a review in focal-onset seizures in patients with epilepsy. CNS Drugs. 2018 May;32(5):473-84. 摘要

73. Feyissa AM. Brivaracetam in the treatment of epilepsy: a review of clinical trial data. Neuropsychiatr Dis Treat. 2019 Sep 9;15:2587-600.全文  摘要

74. Zhou Q, Zheng J, Yu L, et al. Pregabalin monotherapy for epilepsy. Cochrane Database Syst Rev. 2012 Oct 17;(10):CD009429.全文  摘要

75. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomized controlled trial. Lancet. 2007 Mar 24;369(9566):1000-15.全文  摘要

76. Baulac M, Brodie MJ, Patten A, et al. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol. 2012 Jul;11(7):579-88. 摘要

77. Baulac M, Patten A, Giorgi L. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study. Epilepsia. 2014 Oct;55(10):1534-43.全文  摘要

78. Willems LM, Zöllner JP, Paule E, et al. Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence. Expert Rev Clin Pharmacol. 2018 Mar;11(3):309-24. 摘要

79. Bourdet SV, Gidal BE, Alldredge BK. Pharmacologic management of epilepsy in the elderly. J Am Pharma Assoc. 2001 May-Jun;41(3):421-36. 摘要

80. Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018 Sep 3;(9):CD008165.全文  摘要

81. Bergey GK. Initial treatment of epilepsy: special issues in treating the elderly. Neurology. 2004 Nov 23;63(10 suppl 4):S40-8. 摘要

82. Jankovic SM, Dostic M. Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects. Expert Opin Drug Metab Toxicol. 2012 Jan;8(1):81-91. 摘要

83. Marson AG, Appleton R, Baker GA, et al. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess. 2007 Oct;11(37):iii-iv;ix-x;1-134.全文  摘要

84. Bergey GK. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs. Epilepsia. 2005;46 Suppl 9:161-8.全文  摘要

85. Potschka H, Trinka E. Perampanel: does it have broad-spectrum potential? Epilepsia. 2019 Mar;60 Suppl 1:22-36.全文  摘要

86. Tyrlikova I, Brazdil M, Rektor I, et al. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures. Expert Rev Neurother. 2019 Jan;19(1):5-16. 摘要

87. Colleran N, O Connor T, O Brien JJ. Anti epileptic drug trials for patients with drug resistant idiopathic generalised epilepsy: a meta-analysis. Seizure. 2017 Oct;51:145-56.全文  摘要

88. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology. 2004 Apr 27;62(8):1261-73.全文  摘要

89. Bresnahan R, Panebianco M, Marson AG. Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures. Cochrane Database Syst Rev. 2020 Jul 1;(7):CD007783.全文  摘要

90. Bresnahan R, Panebianco M, Marson AG. Brivaracetam add-on therapy for drug-resistant epilepsy. Cochrane Database Syst Rev. 2019 Mar 28;(3):CD011501.全文  摘要

91. Bresnahan R, Martin-McGill KJ, Williamson J, et al. Clobazam add-on therapy for drug-resistant epilepsy. Cochrane Database Syst Rev. 2019 Oct 22;(10):CD004154.全文  摘要

92. Bresnahan R, Hounsome J, Jette N, et al. Topiramate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2019 Oct 23;(10):CD001417.全文  摘要

93. Mbizvo GK, Dixon P, Hutton JL, et al. Levetiracetam add-on for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2020 Jun 30;(6):CD001901.全文

94. Brigo F, Lattanzi S, Igwe SC, et al. Zonisamide add-on therapy for focal epilepsy. Cochrane Database Syst Rev. 2020 Jul 24;(7):CD001416.全文  摘要

95. Panebianco M, Al-Bachari S, Hutton JL, et al. Gabapentin add-on treatment for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2021 Jan 12;(1):CD001415.全文  摘要

96. Panebianco M, Bresnahan R, Hemming K, et al. Pregabalin add-on for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2019 Jul 9;(7):CD005612.全文  摘要

97. Sheng J, Liu S, Qin H, et al. Drug-resistant epilepsy and surgery. Curr Neuropharmacol. 2018;16(1):17-28.全文  摘要

98. Englot DJ, Berger MS, Barbaro NM, et al. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia. 2012 Jan;53(1):51-7. 摘要

99. Englot DJ, Wang DD, Rolston JD, et al. Rates and predictors of long-term seizure freedom after frontal lobe epilepsy surgery: a systematic review and meta-analysis. J Neurosurg. 2012 May;116(5):1042-8. 摘要

100. Boon P, De Cock E, Mertens A, et al. Neurostimulation for drug-resistant epilepsy: a systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response. Curr Opin Neurol. 2018 Apr;31(2):198-210. 摘要

101. Englot DJ, Rolston JD, Wright CW, et al. Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy neurosurgery. 2016 Sep;79(3):345-53.全文  摘要

102. Redgrave J, Day D, Leung H, et al. Safety and tolerability of transcutaneous vagus nerve stimulation in humans; a systematic review. Brain Stimul. 2018 Nov - Dec;11(6):1225-38. 摘要

103. Wang HJ, Tan G, Zhu LN, et al. Predictors of seizure reduction outcome after vagus nerve stimulation in drug-resistant epilepsy. Seizure. 2019 Mar;66:53-60.全文  摘要

104. Li MCH, Cook MJ. Deep brain stimulation for drug-resistant epilepsy. Epilepsia. 2018 Feb;59(2):273-90. 摘要

105. Chang B, Xu J. Deep brain stimulation for refractory temporal lobe epilepsy: a systematic review and meta-analysis with an emphasis on alleviation of seizure frequency outcome. Childs Nerv Syst. 2018 Feb;34(2):321-7. 摘要

106. Jobst BC, Kapur R, Barkley GL, et al. Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas. Epilepsia. 2017 Jun;58(6):1005-14.全文  摘要

107. Geller EB, Skarpaas TL, Gross RE, et al. Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia. 2017 Jun;58(6):994-1004.全文  摘要

108. Heck CN, King-Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia. 2014 Mar;55(3):432-41.全文  摘要

109. Strozzi I, Nolan SJ, Sperling MR, et al. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev. 2015;(2):CD001902.全文  摘要

110. Hixson JD. Stopping antiepileptic drugs: when and why? Curr Treat Options Neurol. 2010 Sep;12(5):434-42.全文  摘要

111. US Food and Drug Administration (FDA). Orphan drug designations and approvals: topiramate injection. Jul 2013 [internet publication].全文

112. Bruno E, Viana PF, Sperling MR, et al. Seizure detection at home: Do devices on the market match the needs of people living with epilepsy and their caregivers? Epilepsia. 2020 Nov;61 Suppl 1:S11-S24.全文  摘要

113. Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology. 2008 Jan 1;70(1):54-65.全文  摘要

114. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus: report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015 Oct;56(10):1515-23.全文  摘要

115. Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015 Jun;14(6):615-24. 摘要

116. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012 Feb 16;366(7):591-600.全文  摘要

117. Treiman DM, Meyers PD, Walton NY, et al; Veterans Affairs Status Epilepticus Cooperative Study Group. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med. 1998 Sep 17;339(12):792-8.全文  摘要

118. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011 Oct;10(10):922-30.全文  摘要

119. Wheless JW. Acute management of seizures in the syndromes of idiopathic generalized epilepsies. Epilepsia. 2003;44(suppl 2):22-6. 摘要

120. National Institute for Health and Care Excellence. Epilepsies: diagnosis and management. May 2021 [internet publication].全文

121. Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb;16(1):48-61.全文  摘要

122. Harden C, Tomson T, Gloss D, et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2017 Apr 25;88(17):1674-80.全文  摘要

123. Ryvlin P, Cucherat M, Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol. 2011 Nov;10(11):961-8. 摘要

124. Maguire MJ, Jackson CF, Marson AG, et al. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP). Cochrane Database Syst Rev. 2020 Apr 2;4:CD011792.全文  摘要

125. Patsalos PN, Spencer EP, Berry DJ. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update. Ther Drug Monit. 2018 Oct;40(5):526-548.全文  摘要

内容使用需遵循免责声明